Form SCHEDULE 13G Quince Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P. Aug 14, 2026 06:09AM
Quince acquires Orphai for LAM-001 drug, raises up to $187 million May 18, 2026 09:27AM
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline May 18, 2026 09:26AM